Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Study Comparing the Use of Daclizumab vs Thymoglobulin as Induction Therapy in Lung Transplantation

NCT00181142 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT00181142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00181142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Study Comparing the Use of Daclizumab vs Thymoglobulin as Induction Therapy in Lung Transplantation
Lead sponsor
Johns Hopkins University
Phase
Phase 2/3
Overall status
Completed
Start date
October 31, 1999
Completion date
December 31, 2004
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients active and listed for lung transplantation